Their etiologies involve de novo methylation of the MLH1 gene. Some cancers have symptoms that include disruption of Rb and the p53 pathway, and uncontrolled proliferation. Their etiologies involve de novo methylation of various gene promoters. Their etiologies involve loss of imprinting. Leukemia has symptoms that include disturbed hematopoiesis.
Rubinstein—Taybi syndrome has symptoms that include intellectual disabilities. Its etiology involves mutation in CREB-binding protein histone acetylation.
Coffin—Lowry syndrome has symptoms that include intellectual disabilities. Its etiology involves mutation in Rsk-2 histone phosphorylation. Disrupting any of the three systems that contribute to epigenetic alterations can cause abnormal activation or silencing of genes.
Such disruptions have been associated with cancer , syndromes involving chromosomal instabilities, and mental retardation Table 1. The first human disease to be linked to epigenetics was cancer, in Because methylated genes are typically turned off, loss of DNA methylation can cause abnormally high gene activation by altering the arrangement of chromatin.
On the other hand, too much methylation can undo the work of protective tumor suppressor genes. However, there are stretches of DNA near promoter regions that have higher concentrations of CpG sites known as CpG islands that are free of methylation in normal cells.
These CpG islands become excessively methylated in cancer cells, thereby causing genes that should not be silenced to turn off. This abnormality is the trademark epigenetic change that occurs in tumors and happens early in the development of cancer Egger et al. Hypermethylation of CpG islands can cause tumors by shutting off tumor-suppressor genes. In fact, these types of changes may be more common in human cancer than DNA sequence mutations Figure 2.
Furthermore, although epigenetic changes do not alter the sequence of DNA, they can cause mutations. About half of the genes that cause familial or inherited forms of cancer are turned off by methylation.
Hypermethylation can also lead to instability of microsatellites, which are repeated sequences of DNA. Microsatellites are common in normal individuals, and they usually consist of repeats of the dinucleotide CA. Too much methylation of the promoter of the DNA repair gene MLH1 can make a microsatellite unstable and lengthen or shorten it Figure 2. Fragile X syndrome is the most frequently inherited mental disability, particularly in males.
Both sexes can be affected by this condition, but because males only have one X chromosome , one fragile X will impact them more severely.
Indeed, fragile X syndrome occurs in approximately 1 in 4, males and 1 in 8, females. People with this syndrome have severe intellectual disabilities, delayed verbal development, and "autistic-like" behavior Penagarikano et al. Fragile X syndrome gets its name from the way the part of the X chromosome that contains the gene abnormality looks under a microscope; it usually appears as if it is hanging by a thread and easily breakable Figure 3.
The syndrome is caused by an abnormality in the FMR1 fragile X mental retardation 1 gene. However, individuals with over repeats have a full mutation , and they usually show symptoms of the syndrome.
This methylation turns the gene off, stopping the FMR1 gene from producing an important protein called fragile X mental retardation protein. Loss of this specific protein causes fragile X syndrome.
Although a lot of attention has been given to the CGG expansion mutation as the cause of fragile X, the epigenetic change associated with FMR1 methylation is the real syndrome culprit. Fragile X syndrome is not the only disorder associated with mental retardation that involves epigenetic changes. Because so many diseases, such as cancer, involve epigenetic changes, it seems reasonable to try to counteract these modifications with epigenetic treatments.
These changes seem an ideal target because they are by nature reversible, unlike DNA sequence mutations. The most popular of these treatments aim to alter either DNA methylation or histone acetylation. Inhibitors of DNA methylation can reactivate genes that have been silenced. These medications work by acting like the nucleotide cytosine and incorporating themselves into DNA while it is replicating. Drugs aimed at histone modifications are called histone deacetylase HDAC inhibitors. Blocking this process with HDAC inhibitors turns on gene expression.
Caution in using epigenetic therapy is necessary because epigenetic processes and changes are so widespread. To be successful, epigenetic treatments must be selective to irregular cells; otherwise, activating gene transcription in normal cells could make them cancerous, so the treatments could cause the very disorders they are trying to counteract.
Despite this possible drawback, researchers are finding ways to specifically target abnormal cells with minimal damage to normal cells, and epigenetic therapy is beginning to look increasingly promising. Egger, G. Epigenetics in human disease and prospects for epigenetic therapy. Nature , — doi Feinberg, A. Hypomethylation distinguishes genes of some human cancers from their normal counterparts.
Nature , 89—92 doi Jones, P. The fundamental role of epigenetic events in cancer. Nature Reviews Genetics 3 , — doi Kaati, G. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. European Journal of Human Genetics 10 , — Penagarikano, O. The pathophysiology of fragile X syndrome. Annual Review of Genomics and Human Genetics 8 , — doi Robertson, K. DNA methylation and chromatin: Unraveling the tangled web.
Oncogene 21 , — doi Epigenetic Influences and Disease. Birth Defects: Causes and Statistics. Birth Defects: Prevention and Treatment.
Copy Number Variation and Genetic Disease. Genetic Causes of Adult-Onset Disorders. Somatic Mosaicism and Chromosomal Disorders. Likewise, some epigenetic changes increase your cancer risk. For example, having a mutation in the BRCA1 gene that prevents it from working properly makes you more likely to get breast and other cancers.
While cancer cells have increased DNA methylation at certain genes, overall DNA methylation levels are lower in cancer cells compared with normal cells. Different types of cancer that look alike can have different DNA methylation patterns.
Epigenetics can be used to help determine which type of cancer a person has or can help to find hard to detect cancers earlier. Epigenetics alone cannot diagnose cancer, and cancers would need to be confirmed with further screening tests. Example: Colorectal Cancer. Some of these changes can remain for decades and might make the child more likely to get certain diseases.
Example: Dutch Hunger Winter Famine More Information. Genetics: Genetic Science Learning Center at the University of Utah external icon provides a detailed explanation and interactive tutorial about epigenetics National Human Genomic Research Institute: Epigenomics Fact Sheet external icon provides answers to questions about the epigenome National Institute of Environmental Health Sciences: Epigenetics external icon provides information about epigenetics, epigenetic research, and a video about epigenetics.
Front Cell Infect Microbiol ; Clin Epigenetics ; 8: PLoS One ; 9:e Food and Drug Administration. Epi proColon pdf icon external icon. Roseboom T. J Endocrinol Hum Mol Genet ; Sci Adv ; 4:eaao Epigenetics ; 7: Epigenetics ; Links with this icon indicate that you are leaving the CDC website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link. Histones are structural proteins in the cell nucleus. DNA wraps around histones, giving chromosomes their shape. Histones can be modified by the addition or removal of chemical groups, such as methyl groups or acetyl groups each consisting of two carbon, three hydrogen, and one oxygen atoms. The chemical groups influence how tightly the DNA is wrapped around histones, which affects whether a gene can be turned on or off.
Errors in the epigenetic process, such as modification of the wrong gene or failure to add a chemical group to a particular gene or histone, can lead to abnormal gene activity or inactivity. Altered gene activity, including that caused by epigenetic errors, is a common cause of genetic disorders. Conditions such as cancers, metabolic disorders, and degenerative disorders have been found to be related to epigenetic errors. Scientists continue to explore the relationship between the genome and the chemical compounds that modify it.
In particular, they are studying the effects that epigenetic modifications and errors have on gene function, protein production, and human health. Other chapters in Help Me Understand Genetics. Genetics Home Reference has merged with MedlinePlus.
0コメント